253 related articles for article (PubMed ID: 10418954)
1. European Commission--Directorate General DG XXIV Consumer Policy and Consumer Health Protection. Notes of Guidance for testing of cosmetic ingredients for their safety evaluation (Second Revision). Adopted: 20 December 1996. Revised: 16 January 1997. The Scientific Committee on Cosmetology of the European Commission.
Food Chem Toxicol; 1999 Apr; 37(4):357-85. PubMed ID: 10418954
[No Abstract] [Full Text] [Related]
2. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
Vinardell MP
Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
[TBL] [Abstract][Full Text] [Related]
3. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
[TBL] [Abstract][Full Text] [Related]
4. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
5. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
6. A perspective on the safety of cosmetic products: a position paper of the American Council on Science and Health.
Ross G
Int J Toxicol; 2006; 25(4):269-77. PubMed ID: 16815815
[TBL] [Abstract][Full Text] [Related]
7. The 7th Amendment to the Cosmetics Directive.
Ruet Rossignol M
Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
[No Abstract] [Full Text] [Related]
8. Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients.
Vinken M; Pauwels M; Ates G; Vivier M; Vanhaecke T; Rogiers V
Arch Toxicol; 2012 Mar; 86(3):405-12. PubMed ID: 22038139
[TBL] [Abstract][Full Text] [Related]
9. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
;
Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring cosmetic product safety].
Vigan M
Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S55-8. PubMed ID: 17563716
[No Abstract] [Full Text] [Related]
11. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
Pauwels M; Rogiers V
Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
[TBL] [Abstract][Full Text] [Related]
12. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
[TBL] [Abstract][Full Text] [Related]
13. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
14. [Expected change of direction in Polish law regarding cosmetics].
Karłowski K; Smietanka B; Biernat U; Burzyńska I; Pawłowska K
Rocz Panstw Zakl Hig; 2004; 55(1):21-5. PubMed ID: 15307612
[TBL] [Abstract][Full Text] [Related]
15. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
16. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
Rogiers V
Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
[No Abstract] [Full Text] [Related]
17. Cosmetic products and their current European regulatory framework.
Rogiers V; Pauwels M
Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
[No Abstract] [Full Text] [Related]
18. REACH: impact on the US cosmetics industry?
Pouillot A; Polla B; Polla A
J Cosmet Dermatol; 2009 Mar; 8(1):3-7. PubMed ID: 19250158
[TBL] [Abstract][Full Text] [Related]
19. Final report of the cosmetic ingredient review expert panel on the safety assessment of Polyisobutene and Hydrogenated Polyisobutene as used in cosmetics.
Int J Toxicol; 2008; 27 Suppl 4():83-106. PubMed ID: 19101833
[TBL] [Abstract][Full Text] [Related]
20. [Cosmetic products : Safety aspects].
Platzek T; Krätke R; Schulz C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
